CDC awards URMC $9M to study emerging infections

The University of Rochester (N.Y.) Medical Center will receive $9 million over the next five years from the CDC to continue its infectious disease surveillance efforts and conduct research to better understand and prepare for emergent pathogens.

The grant marks a renewal of the university's membership in the CDC's Emerging Infections Program. The EIP is a nationwide network that monitors several infectious threats and, through research, looks to inform clinical policy related to prevention and treatment.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox

"This is the largest national surveillance system for infectious diseases, and most of what we know about the burden of infectious disease in the U.S. comes from the research conducted in this network," said Nancy Bennett, MD, director of the Center for Community Health at URMC. "This is our 20th year working with the CDC. Rochester is an ideal community for this research due to the incredible collaboration of physicians, healthcare institutions and laboratories in our region."

More articles on infection control: 
Marquette University issues public health advisory after mumps detection 
Study: African Americans less likely to get flu shot 
Rethinking hand hygiene: 5 things to know about the little-known world of skin microbiota

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

>